PHARMERICA CORPORATION (NYSE:PMC) Files An 8-K Submission of Matters to a Vote of Security Holders

10

PHARMERICA CORPORATION (NYSE:PMC) Files An 8-K Submission of Matters to a Vote of Security Holders

Item 5.07


Submission of Matters to a Vote of Security Holders.

The 2017 Annual Meeting of Stockholders of PharMerica Corporation
(the Company) was held on June 14, 2017.

1.
The Companys stockholders approved the election of the
following seven directors for a term to expire at the
Annual Meeting of Stockholders in 2018. The votes for
each director were as follows:


Name


For


Withheld

Authority


Broker Non-

Votes


Frank E. Collins, Esq.

26,260,958

145,961

3,402,081


W. Robert Dahl, Jr.

26,314,884

92,035

3,402,081


Marjorie W. Dorr

26,322,611

84,308

3,402,081


Patrick G. LePore

26,295,796

111,123

3,402,081


Geoffrey G. Meyers

26,301,570

105,349

3,402,081


Robert A. Oakley, Ph.D.

26,313,704

93,215

3,402,081


Gregory S. Weishar

26,317,775

89,144

3,402,081

2.
The Companys stockholders voted upon the ratification of
the appointment of KPMG LLP as the Companys independent
registered public accounting firm for the fiscal year
ending December 31, 2017. The votes on this proposal were
as follows:


For


Against


Abstained


29,719,945


81,839


7,216

3.
The Companys stockholders voted upon and approved, by
advisory vote, the compensation of the Companys named
executive officers. The votes on this proposal were as
follows:


For


Against


Abstained


Broker Non-Votes


25,173,015


1,181,809


52,095


3,402,081

4.
The Companys stockholders voted upon and approved, by
advisory vote, one year as the frequency of the advisory
vote on executive compensation in future years. The votes
on this proposal were as follows:


One Year


Two Years


Three Years


Abstained


Broker Non-Votes


19,874,255


11,468


6,475,964


45,232


3,402,081

5.
The Companys stockholders voted upon and approved, by
advisory vote, a stockholder proposal regarding simple
majority vote. The votes on this proposal were as
follows:


For


Against


Abstained


Broker Non-Votes


23,545,772


2,803,577


57,570


3,402,081


About PHARMERICA CORPORATION (NYSE:PMC)

PharMerica Corporation is an institutional pharmacy services company. The Company services healthcare facilities, provides pharmacy management services to hospitals, provides specialty infusion services to patients outside a hospital setting and offers the national oncology pharmacy in the United States. It has three segments: institutional pharmacy, specialty infusion services and specialty oncology pharmacy. Its institutional pharmacy segment provides pharmacy products and services to residents and patients in skilled nursing facilities, nursing centers, assisted living facilities, hospitals and other long-term alternative care settings. Its specialty infusion services segment provides specialty infusion services focused on providing pharmaceutical products and clinical services to patients in client facilities, hospice and outside of hospital. Its specialty oncology pharmacy segment provides dispensing of oncology drugs, care management and other related services.

An ad to help with our costs